Commonwealth Equity Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
11,842
+1,143
+11% +$122K ﹤0.01% 2426
2025
Q4
$1.1M Buy
10,699
+28
+0.3% +$2.72K ﹤0.01% 2500
2025
Q3
$964K Sell
10,671
-2,616
-20% -$229K ﹤0.01% 2618
2025
Q2
$1.17M Sell
13,287
-5,339
-29% -$463K ﹤0.01% 2436
2025
Q1
$1.7M Buy
18,626
+660
+4% +$59.4K ﹤0.01% 2041
2024
Q4
$1.55M Buy
17,966
+631
+4% +$57.1K ﹤0.01% 2049
2024
Q3
$1.65M Sell
17,335
-1,691
-9% -$161K ﹤0.01% 1946
2024
Q2
$1.74M Sell
19,026
-2,263
-11% -$202K ﹤0.01% 1882
2024
Q1
$1.93M Buy
21,289
+6,655
+45% +$583K ﹤0.01% 1814
2023
Q4
$1.19M Sell
14,634
-4,317
-23% -$339K ﹤0.01% 2050
2023
Q3
$1.51M Buy
18,951
+422
+2% +$34K ﹤0.01% 1796
2023
Q2
$1.46M Sell
18,529
-314
-2% -$24.6K ﹤0.01% 1836
2023
Q1
$1.46K Sell
18,843
-1,894
-9% -$146K ﹤0.01% 1767
2022
Q4
$1.61M Buy
20,737
+4,688
+29% +$346K ﹤0.01% 1641
2022
Q3
$1.08M Sell
16,049
-307
-2% -$22.6K ﹤0.01% 1841
2022
Q2
$1.26M Buy
16,356
+683
+4% +$53.3K ﹤0.01% 1716
2022
Q1
$1.25M Sell
15,673
-2,629
-14% -$201K ﹤0.01% 1825
2021
Q4
$1.41M Buy
18,302
+1,815
+11% +$135K ﹤0.01% 1735
2021
Q3
$1.2M Buy
16,487
+402
+2% +$30K ﹤0.01% 1784
2021
Q2
$1.18M Sell
16,085
-732
-4% -$52.2K ﹤0.01% 1799
2021
Q1
$1.16M Buy
16,817
+2,367
+16% +$163K ﹤0.01% 1693
2020
Q4
$960K Buy
14,450
+1,760
+14% +$113K ﹤0.01% 1678
2020
Q3
$788K Buy
12,690
+1,572
+14% +$99.4K ﹤0.01% 1643
2020
Q2
$692K Buy
+11,118
New +$672K ﹤0.01% 1654

Other funds holding PPH

Commonwealth Equity Services's PPH Position: Q1 2026 in Review

Commonwealth Equity Services increased its VanEck Pharmaceutical ETF (PPH) stake by 11% in Q1 2026, buying an estimated $122K and bringing the position to 11,842 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

Commonwealth Equity Services first reported a position in PPH in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.93M in Q1 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Commonwealth Equity Services held 11,842 shares of VanEck Pharmaceutical ETF worth $1.23M as of Q1 2026.
  • Commonwealth Equity Services bought 1,143 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $122K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2426 holding.
  • Commonwealth Equity Services first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and has held it in 24 quarters since.
  • Commonwealth Equity Services's VanEck Pharmaceutical ETF position peaked at $1.93M in Q1 2024.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.